chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable; Chills; Feeling tired; A lot of headache; A lot of nausea; Fever; Vomiting; Back pain; Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), CHEST PAIN (Chest pain), PRURITUS (A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable), CHILLS (Chills) and FATIGUE (Feeling tired) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter. .  Concomitant products included CELECOXIB (CELEXA [CELECOXIB]) for an unknown indication.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced BACK PAIN (Back pain), CHEST PAIN (Chest pain), CHILLS (Chills), FATIGUE (Feeling tired), HEADACHE (A lot of headache), NAUSEA (A lot of nausea), PYREXIA (Fever) and VOMITING (Vomiting). On 09-May-2021, the patient experienced PRURITUS (A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Chills, at an unspecified dose and frequency. On 10-May-2021, BACK PAIN (Back pain), CHEST PAIN (Chest pain), CHILLS (Chills), FATIGUE (Feeling tired), HEADACHE (A lot of headache), NAUSEA (A lot of nausea), PYREXIA (Fever) and VOMITING (Vomiting) had resolved. At the time of the report, PRURITUS (A lot of itchiness in all my body, head, like an allergy/Itchiness is unstoppable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: psoriasis, non alcohol user, and non smoker, and other pre-existing medical conditions included: Patient had no known drug allergies. Patient had no drug abuse or illicit drug usage. Patient took the product as directed. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-NOV-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-NOV-2021, the patient experienced initially felt energized. On 12-NOV-2021, the patient experienced felt tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from initially felt energized on 11-NOV-2021, and felt tired on 13-NOV-2021. This report was non-serious.
Information has been received from a nurse referring to an unspecified number of unknown patients of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On unknown dates, the patients were vaccinated with improperly stored doses of M-M-R II (lot#, expiration date, dose and route were unknown). It was reported that the vaccine was improperly stored at 51.2 Fahrenheit for 23 minutes. There was no previous temperature excursion. Data logger was not involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Leg spasm; rashes at her back that turned to burnt red raw.; rashes at her back that turned to burnt red raw.; This is a spontaneous report from contactable consumer or other non-health care professional (patient) via Pfizer-sponsored program Covax US Support. A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: not reported, Expiry date: unknown) via an unspecified route of administration on 08Mar2021 as DOSE 2, SINGLE for covid-19 immunization. Medical history included surgery 4 years ago and had a vein procedure yesterday. The patient's concomitant medications were not reported. The patient experienced rashes at her back that turned to burnt red raw in Mar2021.On 12Mar2021(the day of reporting), the patient experienced leg spasm and wants to know if she can take an antibiotic or not. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained. No further information is expected.
48 hours after immunizations. Pt-with severe crying and irritability for almost 24 hours. Unable to be calmed, inconsoleable. ( Had simialiar, but less severe, episode after 1st DTaP)
COVID-19 Lot # FE3590 Vial PAA165969 Exp was placed in the freezer after we received it. It should have been pulled out of the freezer on 10/19/2021 at 12:00PM according to the storage guidelines and place in the refrigerator for 31 days. Our staff did not pull the vial out of the freezer on this date. The staff noticed the date this morning, November 2, 2021 at 0830.  There were 22 patients who received the covid vaccination during this time frame. The vials were pulled out of the freezer, thawed, and diluted per instructions during 10/19/21 through November 1, 2021. There are 27 vials that were not used and have been set aside to waste.
I received two Johnson and Johnson covid19 vaccines and shortly after, developed high BP. My BP was perfectly fine before your ineffective and dangerous vaccines. Despite MANY months of trying to get it back to perfect 120/80 or less that it was for 60 yrs with lifestyle changes, my BP got worse FROM THE DAMAGED CUASED TO MY VESSELS FROM THE DANGEROUS VACCINE. First I was Rxed Losartan but that didn't work well and then caused high blood K so I had to stop it. I was prescribed 10mg of Lisinopril, I took one dose on 4/18 and went to bed only to be woken up by a loud tapping/pounding in my head/ears. The next day and still two, I have LOUD tinnitus. I only took the one dose and figured anything that causes this horrific tinnitus is damaging. This is a problem of MANY people and its likely damaging their ears. Why would you keep such an obvious Ototoxic product on the market? This better go away.
Vaqta was administred to a 2 month old; No patient experienced symptoms; This spontaneous report was received from a physician via a company representative regarding a 2-month-old infant. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug allergies or reactions were not reported.   On an unknown date, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) injection (strength, dose, route of administration, anatomical location, lot number, and expiration date were not reported) for prophylaxis (product administered to patient of inappropriate age). No adverse events were reported, nor product quality complains involved.   This is one of the two reports received from the same reporter.; Sender's Comments:  US-009507513-2007USA006351:
Dr called local public health nurse to determine if the pt did have reaction. Pt complained of fever 101.3, body and joint aches all over. No rash, edema, hives or reddened skin was noted by MD. Pt did not have shortness of breath, came to Dr next day after shot to c/o sx.
At injection site pt had 3" raised area reddish in color the center 1" to 1 1/2" dark red and hard to the touch. (6/2/2012 9:15 am) pt went to urgent care at 12:00 noon 6/2/12. Diagnosis: Cellulitis and possible drug/drug rxn with current medications prescribed. BACTRIM DS & prednisone.
Haiou needle 3ml 25g 1" needle upon administering the needle did not retract and when removing the syringe, the needle stay in patient's arm and the medication dripped down the patient's arm;  I administered another whole 0.5ml dose in the patient's opposite arm (right arm) and I told the patient I would report to VAERS.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021 at 10:03 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 29-Apr-2021 at 10:03 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 52.77.  No concomitant medications were reported.  Batch number 007C21A underwent temperature excursion on 29-April-2021 with temperature  33 degrees Fahrenheit from 10:00 AM. This vial was moved to fridge on 19-April-2021 and beyond use date for the vial was reported as 19-May-2021. Product moved to clinic on 29-April-2021  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Pt was given high dose vaccine due to improper patient intake at a vaccine clinic provided to the facility. Pt is 61 years old. No adverse reaction reported.
Mom states when driving home, child was white and rigid. Mom took child to hospital was told child had seizure.
bruisingon the neck; Experienced fatigue; This is a spontaneous report from a Pfizer sponsored program Support. A contactable female consumer (Patient) reported for herself:  A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were unknown. On an unspecified date the patient experienced bruising on the neck and fatigue (after getting second dose). The outcome of the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt. had rash/swelling to (L) thigh and pain with ambulation. After 1 dose of BENADRYL symptoms started resolving.
Patient states she developed soreness in her right arm.  Glands became swollen in the throat.  Denies ever having COVID-19 virus. Glands were sore, but not painful.  No swelling in underarms,.  Checked back on 8/18/2021 and patient stated she was doing better.  Had an appointment for follow-up with her doctor on 8/30/2021.   She was seen by doctor on 8/30/2021 at a HCF and was told she was doing okay with no further issues. Contacted on 9/20/2021- patient stated she was doing okay.
Patient was contacted for her second covid vaccine scheduled on 04/29/21 which patient reported she is currently in the hospital being treated for covid.
fever 102.4, whelps all over body;some wheezing, c/o pain in leg x 1;
inflammation; left part of his chest, arm and back Pain is ongoing; left part of his chest pain; left part of his chest, arm  pain; left shoulder muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (inflammation), BACK PAIN (left part of his chest, arm and back Pain is ongoing), CHEST PAIN (left part of his chest pain), PAIN IN EXTREMITY (left part of his chest, arm  pain) and MYALGIA (left shoulder muscle pain) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Janssen and Janssen (DOSE: 1) on 27-Mar-2021. Past adverse reactions to the above products included No adverse reaction with Janssen and Janssen.   On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced BACK PAIN (left part of his chest, arm and back Pain is ongoing), CHEST PAIN (left part of his chest pain), PAIN IN EXTREMITY (left part of his chest, arm  pain) and MYALGIA (left shoulder muscle pain). In February 2022, the patient experienced INFLAMMATION (inflammation). The patient was treated with NAPROXEN for Inflammation, Muscle pain, Chest pain, Back pain and Pain in arm, at an unspecified dose and frequency and INDOMETHACIN [INDOMETACIN] for Inflammation, Muscle pain, Chest pain, Back pain and Pain in arm, at an unspecified dose and frequency. At the time of the report, INFLAMMATION (inflammation) outcome was unknown and BACK PAIN (left part of his chest, arm and back Pain is ongoing), CHEST PAIN (left part of his chest pain), PAIN IN EXTREMITY (left part of his chest, arm  pain) and MYALGIA (left shoulder muscle pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, X-ray: inflammation patient went to ER and got X rays- according to the HCP has inflammation.   Concomitant medication includes: High blood pressure medication Following the vaccination the patient experienced events in third week of November. Reporter reported that the patient took naproxen and Indomethacin anti-inflammatory medication which didn't help.
the plastic broke off in the actual vial. They cannot use one dose of the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received rsv vaccine prot.subunit pref 2v (ABRYSVO), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEVICE BREAKAGE (non-serious), outcome "unknown", described as "the plastic broke off in the actual vial. They cannot use one dose of the vaccine".  Causality for "the plastic broke off in the actual vial. they cannot use one dose of the vaccine" was determined associated to device constituent of rsv vaccine prot.subunit pref 2v (malfunction).  Additional information: He said that the customer had an issue with a dose of the Abrysvo vaccine, the vial adapter that comes with it, the plastic broke off in the actual vial. They cannot use one dose of the vaccine. Reportability Determination: This complaint for customer had an issue with a dose of the Abrysvo vaccine, the vial adapter that comes with it, the plastic broke off in the actual vial. They cannot use one dose of the vaccine is a reportable malfunction; if it were to recur, it could likely cause or contribute to death or serious injury.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 73-year-old female patient who received SHINGRIX (batch number L9CS4, expiry date 22nd February 2021) for prophylaxis. In August 2018, the patient received the 1st dose of SHINGRIX. In September 2018, less than a year after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: This case was reported by Pharmacy Technician. At the end of September 2018, the patient developed shingles. The healthcare professional wanted to know when the patient should receive the 2nd dose of SHINGRIX. The healthcare professional consented to follow up.
Chicken Pox; fevers; This is a spontaneous report from a contactable consumer (patient's wife). A male patient (reporter's husband) of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6203) via an unspecified route of administration in left arm on 03Mar2021 at 10:30 as single dose for COVID-19 immunization. Medical history, concomitant medications or past drug history of the patient were not reported. On an unspecified in 2021, patient experienced chicken Pox, and was totally covered from head to toe, had fever and missed 3 weeks of work. Outcome of the events were unknown.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a medical assistant refers to a male patient of unknown age. On 25-SEP-2014, the patient was vaccinated with a dose of (Merck) VARIVAX lot # J004812, expiration date 18-APR-2015 (route was not provided). On 25-SEP-2014, the patient received improperly stored (Merck) VARIVAX. No adverse effects were reported. It was unknown if the patient sought medical attention. At the time of the report, the patient's status was unknown. This is one of several reports received from the same source. Additional information is not expected. No further information is available.
AT FIRST HAD PAIN/TENDERNESS AT INJECTION SITE LIKE THE FIRST SHOT BUT NOT NEARLY AS BAD, BUT AFTER 24 HOURS, I HAD AN ACHY PAIN RADIATING FROM MY ELBOW TO MY FINGERTIPS AND HAD PINS AND NEEDLES ONE NIGHT.  THE PAIN IS SIMILAR TO CARPEL TUNNEL PAIN.  IT HAS NOT RESOLVED.  I'VE BEEN BRACING IT AND WILL START TAKING OVER THE COUNTER ANTI-INFLAMMATORY PAIN MEDICINE.  JUST WANTED TO REPORT IT B/C I HAVEN'T SEEN ANYONE ELSE REPORT THIS KIND OF REACTION.  IT IS MY LEFT ARM; MY NON-DOMINANT ARM AND I HAVE NEVER HAD THIS SORT OF PAIN IN MY LEFT ARM.
Patient vaccinated on 8/29/07 with Menactra.  Was admitted facility with severe meningococcal meningitis on 1/28/08.  Serogroup Y by public health lab.  Patient recovering well.  He is currently under my care I contacted Sanofi Pasteur about the case and they requested that I submit a VAERS. 3/24/08-records received for DOS 1/29-2/4/08-DC DX: Bacterial Meningitis, Neisseria Meningitidis. Presented with 2 day C/O fever, and not feeling well, 2 days of emesis with concurrent loose stools. Headache with neck stiffness and cough productive of green sputum with dry sore throat. Photophobia. Bilateral joint pain to upper and lower extremities. Temp 103, tachycardic.
Patient was administered a 5-11yr old bivalent vaccination. Patient should have been given the 6mo-4yr dosage.   Nursing states that the vial of 5-11 vaccine was in the incorrect bin and was then drawn up and labeled as 6mo-4yr. Nursing then administered this dose and it was not caught through medication scanning as it was labeled incorrectly.   Patient family to be notified to monitor for any reactions.
Fever over 101. Severe chills, body aches, headache, nausea 1 week later I had vaginal bleeding for 3 days with cramping.  Prior to this I had not had a period in over 7 years.
The worst excrutiatingly horrible pain I have ever experienced in my 88 years began on the evening of 10 November 2023. It ocurred about 33 hours after the high dose flu shot was administered.  The pain was so bad in my neck, back, and shoulders, I could not sleep in any position for five consecutive nights. The adverse reaction has left me with risidual neck and shoulder pain, and headaches.  Additionally, it has caused me to have limited range of motion (very painful to raise or lower head and/or turn head left or right.  Driving a vehicle safely has become both difficult and challenging. To this day (nine days later), my sleep is constantly interrupted by pain at night and my daily chores are curtailed by fatigue.   A Orthopedist took x-rays, and prescribed both muscle relaxers and physical therapy. I have had only one of twenty physical therapy sessions allowed. However, it's far to early to determine a benefit.
When I woke up at 7:00AM the day following the injection I had fatigue headache and ringing in my ears The headache and fatigue were gone by 3:00 PM It is 10/30/21 and I still have ringing in my ears that has not improved.
Went to family doctor 11/20/09 to report onset of S/S. 11/18/09. Pain behind left ear. Right side facial weakness was assessed by Doctor who's name we do not know however Doctor wants questions to him.
pt cried all day & noc, had a fever (no sure how high) this leg was red & swollen around the site of inj;s/s lasted 48hr;
Very bad severe reaction with the booster vaccine; Severe neck pain; Arm sore; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Very bad severe reaction with the booster vaccine), NECK PAIN (Severe neck pain), PAIN IN EXTREMITY (Arm sore) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Very bad severe reaction with the booster vaccine), NECK PAIN (Severe neck pain), PAIN IN EXTREMITY (Arm sore) and PYREXIA (Fever). At the time of the report, VACCINATION COMPLICATION (Very bad severe reaction with the booster vaccine), NECK PAIN (Severe neck pain), PAIN IN EXTREMITY (Arm sore) and PYREXIA (Fever) outcome was unknown.No Concomitant medications were provided by the reporter.No Treatment information was reported.